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ABSTRACT 
 
The non-fermenting bacilli (BGN-NF) are frequent hospital microorganisms and cause 
disease by infecting colonization in immunocompromised patients or when they reach 
sterile body sites through invasive hospital procedures such as introduction of catheters and 
ventilators, are therefore considered opportunistic bacteria. This work aimed study the 
epidemiology and antimicrobial resistance of BGN-NF, isolated from infectious process of 
patients admitted in a public hospital in Campina Grande-PB, in the period April 2009 to 
March 2011. Of the 1,056 patients analyzed cultures from different clinical specimens, 358 
(33.9 %) presented bacterial growth and were classified as cases of community infections 
(IC) or hospital infections (IH), according to the criteria established by the Law 2616/98 
from the Brazilian Ministry of Health, noting 52 (15%) cases of infection by rods BGN-
NF. Among these, Pseudomonas aeruginosa was most prevalent species with 44 (84.6%) 
of insulation,especially also for high resistance to antimicrobials. The largest number of P. 
aeruginosa, was detected in secretions collected orotracheal tube with 9 (26.4%) cases, 
with prevalence in patients above 60 years. Among the hospital enrironments where these 
microorganisms were more prevalent, the intensive care unit, with 44.2% of cases. There 
was a high resistance of strains of P. aeruginosa from most of the antimicrobials tested. 
Among those who showed good antimicrobial activity, stood out: imipenen with 2 (5.8%) 
and ciprofloxacin and amikacin 7 (20.5%) with drug-resistant strains. Not observed 
difference in resistance between nosocomial and/or communitary strains. 
 
Keywords: Non-fermenter, Hospital Infection, Antibiotic, Resistance. 
 
 
INCIDÊNCIA DE INFECÇÕES HOSPITALARES POR GRAM-NEGATIVOS 
NÃO-FERMENTADORES E PERFIL DE SENSIBILIDADE AOS 
ANTIMICROBIANOS EM UM HOSPITAL EM CAMPINA GRANDE-PB 
 
RESUMO 
Bacilos não fermentadores (BGN-NF) são micro-organismos frequentes em hospitais e 
podem causar doenças infectando pacientes imuocomprometidos ou ainda quando 
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alcançam locais estéreis do corpo através de procedimentos hospitalares invasivos como 
introdução de cateteres e ventiladores, sendo, portanto, consideradas bactérias oportunistas. 
Este trabalho objetivou estudar a epidemiologia e resistência aos antimicrobianos dos 
BGN-NF, isolados de processos infecciosos de pacientes internados, em um hospital da 
rede pública de Campina Grande-PB, no período de abril de 2009 a março de 2011. Dos 
1.056 resultados de culturas analisadas, de diferentes espécimes clínicos, 358 (33,9%) 
apresentaram crescimento e foram classificados como casos de infecções comunitárias (IC) 
ou hospitalares (IH), de acordo com os critérios estabelecidos pela Lei 2616/98 do 
Ministério da Saúde, constatando-se 52 (15%) casos de infecção por bastonetes BGN-NF. 
Dentre estes, Pseudomonas aeruginosa foi a espécie mais prevalente com 44 (84,6%) dos 
isolamentos, destacando-se também pela elevada resistência aos antimicrobianos. O maior 
número de isolamentos de P. aeruginosa, foi detectado nas secreções coletadas do tubo 
orotraqueal com 9 (26,4%) casos, com  predomínio em pacientes acima de 60 anos. Dentre 
os ambientes hospitalares onde estes micro-organismos foram mais prevalentes, destacou-
se a unidade de terapia intensiva, com 44,2% dos casos. Observou-se elevada resistência 
das cepas de P. aeruginosa frente à maioria dos antimicrobianos testados. Dentre os que 
apresentaram boa atividade antimicrobiana, destacaram-se: impenem com 2 (5,8%) e 
ciprofloxacina e amicacina com 7 (20,5%) de cepas resistentes. Não se observou diferença 
no padrão de resistência entre as linhagens nosocomiais e/ou comunitárias. 
Palavras-chave: Não fermetador, infecção nosocomial, antibióticos, resistência. 
 
 
1. INTRODUCTION 
The Gram-negative glucose non-fermenting bacilli (BGN-NF) are widely 
distributed in the environment and can be found in soil, water, food and disinfecting 
solutions (ANVISA, 2011). In hospitals, they are more frequently isolated from water tap, 
respirators, suction catheters, antiseptics, serums, sinks, medical equipment and health 
professionals (PITTET et al., 1999). 
They are responsable for serious infections in hospitals. These bacteria can colonize 
and cause disease after infecting immunocompromised patients or when gain access to 
sites normally sterile in body through hospital procedures such as invasive introduction of 
catheters and respirators. They are considered opportunistic micro-organisms (Volk et al., 
1999), however, some members are recognized as nosocomial pathogens, with significant 
role in colonization and infection of patients admitted to hospitals, causing serious 
complications that can progress to septicemia (FIGUEIREDO et al., 2009; ZANOL; 
PICOLI; MORSCH, 2010).  
They BGN-NF are unable to use carbohydrates as an energy source by 
fermentation, degrading them by oxidative pathway (MURRAY et al., 2003; SANTOS, 
2006). Due to the low metabolic activity compared to enterobacteria, identification 
becomes more complex, so morphologic, macroscopic and microscopic carachteristics are 
essential for the identification process that also requires special tests (Silva Filho et al., 
2007). 
 The phenotypic methods (SANTOS, 2006) have low discriminatory power when 
compared to molecular typing methods (ZANOL; PICOLI; MORSCH, 2010; WOLSKA; 
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JAKUBCAK, 2012), so that phylogenetic studies based on 16S rRNA sequence led to 
numerous changes in the classification and nomenclature of this group of microorganisms 
in recent years. 
Among the major emerging non fermenting bacteria are: Pseudomonas, 
Acinetobacter, Burkholderia, Stenotrophomonas and Chryseobacterium (BROOKE, 2012). 
Pseudomonas aeruginosa and Acinetobacter baumannii pathogens are considered 
ubiquitous and highly prevalent in hospital settings (VOLK et al., 1999) and are often 
isolated from blood cultures and samples of hospital patients respiratory tract 
(DELIBERALI et al., 2011). 
The BGN-NF also have high resistance to several antimicrobial agents 
(FIGUEIREDO et al, 2009; UMADEVI et al., 2011) and are capable of causing serious 
infections, especially in patients of intensive care units (ICU), undergoing invasive 
procedures, burned patients and those with cystic fibrosis (CARVALHO; GONTIJO 
FILHO, 2008; SiLva FILHO et al., 2007). 
Among the Gram-negative bacilli isolated from clinical samples, 68-78% are 
members of the Enterobacteriaceae rods while 12-16% are BGN-NF. However, even at 
lower percentages, these micro-organisms considered as opportunistic, may become severe 
agents of hospital infections, mainly due to the high level of resistance to antimicrobials 
commonly used in these environments (MURRAY et al., 2003). 
This study aimed studying retrospectively the epidemiology and antimicrobial 
resistance of Gram-negative glucose non-fermenting (BGN-NF), isolated from nosocomial 
infections and empiric antibiotic therapy prescribed in a hospital in Campina Grande-PB 
(Brazil). 
        
2. MATERIALS AND METHODS 
 
2.1 Universe Characterization  
 
The research happened at a hospital in Campina Grande - PB, through a 
retrospective and quantitative approach. Data were collected from patient formularies and 
from   the hospital microbiology laboratory information, from April 2009 to March 2011. 
 
2.2 Sampling and Methodology  
 
We analyzed the results of 1,056 cultures. Bacterial growths were found in 358 of 
these cultures from different clinical specimens and were classified as hospital or 
community-acquired infections, according to the criteria established by the Brazilian law 
2616/98 (BRASIL, 1998). Clinical specimens used were: urine, secretions, catheter tip and 
tracheal tube from patients in different wards of the hospital. Culture media used were 
blood agar, mannitol salt agar and Eosin Methylene Blue Agar (EMB). The 
microorganisms were initially identified based on their morphotinctorial features and 
biochemical use of sugars through the Triple Sugar Iron Agar (TSI). A sign of a non-
fermenting bacteria presence was growth in the mentioned medium without change in its 
original color (SADER et al., 2001).  
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In these cases, additional biochemical tests were used for the identification of NF-
BGN, according to the kit for non fermenters used (Probac®) which tested bacterial 
motility, oxidase, glucose utilization in base medium for oxidation/fermentation (OF), 
decarboxylation of lysine and arginine, liquefaction of gelatin, urea hydrolysis, DNAse, 
sensitivity to polymyxin and observation of pigment production. Bacterial identification 
was made by reading the product numbering system. Verification of the microorganisms 
susceptibility to antimicrobials (Cefar®) was performed using antibiogram, by disk 
diffusion method (CLSI, 2006). 
 
2.3 Ethical considerations 
 
This study was approved by the Ethics Committee of the State University of 
Paraíba (UEPB) by the number: 0020.0.133.000-12. 
 
 
3. RESULTS AND DISCUSSION 
 
From 1056 bacterial cultures analyzed in this study, 358 showed bacterial growth. 
52 (15%) isolated were NF BNG-glucose, 59 (16%) Gram positive cocci and 247 (69%) 
were Gram-negative fermenting bacilli - Enterobacteria.  
 
 
Figure 1: Distribution of bacterial groups isolated from patients cultures at a hospital in 
Campina Grande-PB, from April 2009 to March 2011 
The NF-BGN percentage (15%) in this study was considered high when compared 
to other authors who found frequencies of 9.4% and 2.18% of NF-BGN in similar studies 
performed in Brazil (DELIBERALI et al., 2011; MENEZES et al., 2004). The high number 
of positive cultures for BGN-NF should be an alert to health professionals, because the 
great presence of these microorganisms reveals the indiscriminate use of antimicrobials in 
a hospital. However, several authors (MARQUES et al., 2007; PELLEGRINO et al., 2002; 
SADER et al., 2001; VOLK et al., 1999) emphasize that the prevalence of these isolates 
52 (15 %)
59 (16%)
358 (69%)
Bastonete Gram
Negativo Não
Fermentador
Cocos Gram Positivo
Enterobactérias
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can range from one hospital to another and from one study to another within the same 
hospital. 
From the 52 NF-BGN strains found in the hospital studied, 38 (70%) had  
nosocomial origin (IH) and 16 (30%) were  from the community (IC), according to the 
criteria established by the Brazilian law (BRASIL, 1998). 
 
 
Figure 2: Classification of infections by Gram negative non-fermenters bacilli 
             Table 1 shows the distribution by age group of patients with infections caused by 
NF-BNG. The higher frequency of infections occurred in patients above 60 years old, 16 
(42.1%). This fact may be related to several factors as physiological changes of aging, 
decline in immune response and invasive procedures. 
Table 1: Distribution by age group of patients with nosocomial infections (IH) caused by 
Gram negative non-fermenters bacilli (NF-BGN) 
Age group of patients with IH 
Isolations NF - BGN 
n % 
0 – 1 year  3 7.8 
> 1 – 30 years  2 5.2 
> 30 – 60 years  13 34.2 
> 60 years  16 42.1 
Not informed 4 10.5 
Total  38 100.0 
 Source: Archives of  Microbiology Laboratory of the Studied - April 2009 to March 2011. 
Rarely P. aeruginosa as well as other NF-BGN cause community-acquired 
infections in healthy individuals infected. In most cases, these bacteria infect individuals 
with weakened immune system. They are considered opportunistic pathogen, which 
explains its high prevalence in patients with advanced age.  
 
IH
38 (70%)
IC
16 (30%)
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Table 2 demonstrates the diversity of NF-BGN isolated in different hospital 
departments, with a higher frequency of P. aeruginosa, 44 (84.6%). Of these, 34 (77%) 
had nosocomial origin. The Unidade Carea Unit (ICU) showed the largest number of 
patients with BGN-NF infection, with 21 (47%) isolates of P. aeruginosa. Other areas like 
oncology and surgical wards, were also considered critical areas respectively with 11 
(25%) and 7 (15%) isolates. Just one Acinetobacter baumannii was isolated in this study 
from a community origin patient in the oncology area. Other NF-BGN identified were 
Burkholderia cepacia 3 (5.7%), Chryseobacterium indologenes 2 (3.8%), Flavobacterium 
oryzihabitaus 1 (1.9%) and B. pickett, 1 (1.9%). 
 
 
Table 2: Epidemiology of infections caused by Gram negative non-fermenters in 
inpatients in the hospital departments 
 
Microorganisms 
Hospital Departaments 
ICU ONC ALA-C AMB PED TOTAL 
IC IH IC IH IC IH IC IH IC IH N % 
Pseudomonas 
aeruginosas 
 
3 
5,8% 
18  
34,6% 
4 
7,7% 
7 
13,5% 
0 
7 
13,5% 
3 
5,8% 
0 0 
2 
 3,8% 
44 84,6 
Burkholderia 
cepacia 
 
0 
1 
1,9% 
1 
1,9% 
1 
1,9% 
0 0 0 0 0 0 3 5,8 
Chryseobacterium 
indologenes 
 
0 
1 
1,9% 
0 0 0 
1 
1,9% 
0 0 0 0 2 3,8 
Acinetobacter 
baumannii 
 
0 0 
1 
1,9% 
0 0 0 0 0 0 0 1 1,9 
Flavobacterium 
oryzihabitaus 
 
0 0 0 0 0 0 
1 
1,9% 
0 0 0 1 1,9 
Burkholderia 
picketti 
0 0 
1 
1,9% 
0 0 0 0 0 0 0 1 1,9 
Total 23 (44,2%) 15 (28,8%) 8 (15,4%) 4 (7,7%) 2 (3,8) 52 100,0 
Source: Archives of Microbiology Laboratory of the Hospital  of April 2009  to March 2011. Legend: ICU: 
Intensive care unit; ONC: Oncology; ALA-C: Surgical Ward; AMB: Outpatient; PED: Pediatrics, IC: 
Infections Community, IH: Infections Hospital. 
         
  Table 3 lists the origin of the clinical specimens in which P. aeruginosa were 
isolated from hospital origin, confirming that the largest number of isolates were secretions 
from the tracheal tube 9 (26.4%), followed by  urines 7 (20.5%)    secretions from wounds 
6 (16.2%) and surgical wound secretions 3 (8.8%). These results are in agreement with 
literature reports (BRITO et al, 2003; CARVALHO; GONTIJO FILHO, 2008; 
HARINGER, 2009; LISBOA et al., 2007). 
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Table 3: Biological specimens used for the isolation of nosocomial Pseudomonas 
aeruginosa   
Origin of the material analysed  
Samples 
n
 
(%)  
Endotraqueal tube 9 26,4 
Urina 7 20,5 
Wound secretion 6 16,2 
Surgical wound 3 8,8 
Chest drain 2 5,8 
Abdominal fistula 2 5,8 
Lung secretion 1 2,9 
Catheter tip 1 2,9 
Hemoculture 1 2,9 
Others 2 5,8 
Total 34 100,0 
 
    Source: Archives of Microbiology Laboratory of the Studied Hospital - April 2009 to March 2011. 
 
             The high number of P. aeruginosa in the endothracheal tube occured, probably, 
because it can colonize the surface of the respiratory tract, releasing proteases that break 
the mucus mesh rich in fibronectin and exposing the receptors where the  bacteria fimbriae 
bind. Moreover, damaged or irritated tissue due to invasive hospital procedures, facilitates 
the colonization process of Pseudomonas (HARINGER, 2009). 
The secretion culture of endotracheal tube was used to predict the development of 
nosocomial pneumonia in patients with endotracheal breathing, as well as with other 
patients parameters like chest X-ray. Data used in this study were obtained from the results 
of cultures count with more than 10
6 
colony units formation (CFU), which was the cut to 
dismiss the possibility of tracheal colonization, characterizing pulmonary infection 
(HARINGER, 2009). Several authors (CALDERÓN et al., 2011, CARVALHO; 
GONTIJO, 2008, MARCONI et al, 2008) considers pneumonia as the major cause of 
nosocomial infection in ICU patients, especially when associated with mechanical 
ventilation (HARINGER, 2009). 
Table 4 shows the susceptibility profile of NF-BGN antimicrobials. Meropenem 
was the most effective drug against these microorganisms, followed by imipenem. These 
data agree with the literature reports as to carbapenems being considered the antimicrobial 
therapy of choice for treatment of serious hospital infections caused by NF-BGN (GALES 
et al., 2008). 
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Table 4: Profile of antimicrobial resistance of gram-negative bacilli isolated in this study  
                           Microorganisms 
Antimicrobials 
Pseudomonas 
aeruginosas 
 
n=34 
 
 n            % 
Burkoldera 
cepacia 
 
n=2 
 
 n          % 
Chyseobacteriu 
idologenes 
 
n=2 
 
    n            % 
Escherichia 
coli 
 
n=45 
 
 n           % 
Klebisiella 
spp 
 
n=20 
 
  n            % 
Enterobacter 
spp 
 
n=12 
 
n             % 
AM 
 
7 20,5 0 0 1 50,0 3 6,6 2 10,0 1 8,3 
AZ 
 
2
4 
70,5 1 50,0 1 50,0 12 26,
6 
12 60,0 9 75,0 
CE 
 
3
4 
100 1 50,0 1 50,0 21 46,
6 
13 65,0 11 91,6 
CT 
 
3
4 
100 1 50,0 1 50,0 25 55,
5 
18 90,0 11 91,6 
CP 
 
7 20,5 1 50,0 1 50,0 22 48,
8 
14 70,0 7 58,3 
CL 
 
3
4 
100 1 50,0 1 50,0 12 26,
6 
12 60,0 10 83,3 
GE 
 
1
5 
44,1 0 0 1 50,0 15 33,
3 
12 60,0 8 66,6 
TT 
 
3
4 
100 1 50,0 1 50,0 34 75,
5 
17 85,0 7 58,3 
SU 
 
3
4 
100 2 100 1 50,0 31 68,
8 
17 85,0 9 75,0 
AC 
 
3
4 
100 1 50,0 1 50,0 17 37,
7 
14 70,0 10 83,3 
AP 
 
3
4 
100 1 50,0 2 100 37 82,
2 
17 85,0 12 100 
CM 
 
1
8 
52,9 1 50,0 1 50,0 15 33,
3 
12 60,0 11 91,6 
IM 
 
2 5,8 1 50,0 1 50,0 0 0 1 5,0 1 8,3 
CF 
 
3
3 
97,0 1 50,0 1 50,0 16 35,
5 
14 70,0 8 66,6 
TO 
 
9 26,4 1 50,0 1 50,0 16 35,
5 
14 70,0 8 66,6 
ME 
 
0 0 0 0 0 0 0 0 0 0 1 8,3 
CZ 
 
2
9 
85,2 1 50,0 1 50,0 10 22,
2 
14 70,0 12 100 
CX 
 
3
4 
100 1 50,0 1 50,0 6 13,
3 
13 65,0 8 66,6 
 Legend: AM: Amikacin, AZ: Aztreonam; EC: Cephalexin, CT: Cephalothin, CP: Ciprofloxacin; CL: 
Chloramphenicol; GE: Gentamicin; TT: Tetracycline; SU: Trimethoprim-sulfamethoxazole; AC: 
Amoxicillin-Ac. Clavulônico; AP: Ampicillin, CM: Cefepime, CZ: Ceftazidime, IM: Imipenem, CF: 
Ceftriaxone, TO: Tobramycin, ME: Meropenem, CX: Cefoxitin. 
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The other antimicrobials tested had low or no efficacy. It was observed that 100% 
of the strains were resistant to amoxacilin + clavulanic acid, ampicillin, cephalexin, 
cephalothin, cefoxitin, chloramphenicol, sulfamethoxazole-trimethoprim and tetracycline. 
High percentage of resistant strains, was also found in relation to ceftriaxone 33 (97%), 
ceftazidime 29 (85.2%), aztreonam 24 (70.5%), cefepime 18 (52.9%) and gentamicin 15 
(44,1%). Among the antimicrobials tested against P. aeruginosa, ciprofloxacin showed 
7(20.5%) resistant strains, behavior similar to aminoglycosides: amikacin and tobramycin, 
with only 7 (20.5%) and 9 (26.4%) of resistant strains, respectively. However, it was 
observed higher percentage of resistance in relation to gentamicin with 15 (44.1%) 
resistant strains. These results are in agreement with others reports (SADER et al., 2001; 
LÓPEZ-ROJAS et al., 2011) which also showed similar behavior, although with higher 
percentages: 36.1% and 43.7% respectively for amikacin, and gentamicin (Table 4).  
  There was some discrepancy in the behavior of two (5.8%) strains of P. aeruginosa 
that were resistant to imipenem, but were susceptible to meropenem. This difference 
between the two carbapenems was repeated for the other NF-BGN. These data are in 
agreement with reports of other authors (Gales et al., 2002) who affirm that meropenem 
has better activity than imipenem against P. aeruginosa. However, considering that they 
are similar drugs, it is important that such discrepancy be confirmed by sending the strains 
to research accredited agencies (MARQUES et al., 2007). 
P. aeruginosa resistant to carbapenems have been detected in several parts of the 
world and its control is urgent, since they are the drugs of choice for treatment of 
infections caused by this bacteria (GALES et al., 2002; FIGUEIREDO et al., 2009; PEÑA 
et al., 2012). The frequency of resistant strains to imipenem (5.8%) in this study was much 
lower than those documented in other studies that found rates of 14% to 38.34% in some 
hospitals (PELLEGRINO et al., 2002; TUMITN & PIZZOLITTO, 2003; KALAI et al., 
2004). Despite the good efficacy of imipenem in the treatment of infections caused by P. 
aeruginosa, there is a possible risk of resistance during the therapy using this drug 
(GALES et al., 2002). 
The clinical importance of infection by P. aeruginosa is characterized by the 
expression of multiple antibiotic resistance associated with a difficult disease eradication, 
with high morbidity and mortality (NEVES et al., 2011). 
Amikacin, meropenem and gentamicin were the most effective antibiotics against 
the two strains of Burkolderia cepacia and Chryseobacterium idologene. Meropenem was 
the only drug in which the strains of non-fermenting Gram-negative bacilli showed no 
resistance. Considering the small number of isolates (n = 2) of the B.cepaciae and 
Chryseobacterium idologene, it was not possible to have a good analysis of the level of 
resistance of these species (Table 4). Regarding the behavior of C. idologene, uncommon 
human pathogen (CALDERÓN et al., 2011). 
It was also found that 20.5% of P. aeruginosa strains were resistant to 
ciprofloxacin. However, this value can be considered low compared to other studies where 
authors (MENEZES et al., 2004; PAVIANE; STADNIK; HEINEK, 2004) found 58.0% 
and 37.0% of resistant strains. 
Imipenem has good efficacy in the treatment of infections caused by P. aeruginosa, 
despite the risk of resistance during treatment (GALES et al., 2002). The percentage of 
strains resistant to imipenem (5.8%) found in this study was much lower than those 
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reported by other authors who found values between 14% and 20.4% (TUMITAN; 
PIZZOLITTO, 2003;  Kalaii et al., 2004; TAKAGI et al., 2009). 
All P. aeruginosa were resistant to cefoxitin, cefalexin and cephalothin (Table 4). 
Reports of first and second generation resistant cephalosporins strains are common since P. 
aeruginosa has intrinsic resistance to these antimicrobials (SADER et al., 2001; Peña et al., 
2012). We also observed high percentages of third generation cephalosporins resistant 
strains: 29 (85.2%) resistance strains to ceftazidime and 33 (97%) resistant strains to 
ceftriaxone, cephepime, a fourth generation cephalosporin, was the less resistant drug 
against P. aeruginosa, 18 (52.9%). Other authors (PELLEGRINO et al., 2002; LEISER; 
TOGNIM; BEBENDO, 2007; PIRES et al., 2009) found the same inversion of resistance 
as to cephalosporins generations.  
Resistance to ceftriaxone, ceftazidime and cefepime were also reported in different 
hospitals (SADER et al., 2001; PIRES et al., 2009; MARQUES et al., 2007; LEISER; 
TOGNIM; BEBENDO, 2007), but at levels below the percentage found in this study. 
Considering these results, it is evident that P. aeruginosa has high capacity of developing 
different mechanisms of resistance to cephalosporins. 
             Figure 3 shows the antimicrobials that were being used by patients before the 
microbiological cultures. From the 44 cases of P. aeruginosa infection, 22 (50%) patients 
were already using empirical treatment, with some type of antimicrobial prescribed by the 
doctors of the hospital. It was found that the most commonly prescribed antibiotic was the 
association between ceftriaxone and metronidazole (5 cases), followed by cephalothin and 
ceftriaxone (4 cases each). 
 
Figure 3: Antibiotics used by medical prescription before the identification of P. 
aeruginosa 
  
 
 Source: Archives of Microbiology Laboratory of the Studied Hospital - April 2009 to March 2011  
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          It was found that all patients who were being treated empirically with cephalothin, 
and cephalexin had resistant strains to these antimicrobials, considering the three patients 
who received ciprofloxacin alone or in combination, one demonstrated resistant strains to 
this antimicrobial. From the 12 patients who used ceftriaxone, either in combination with 
other antimicrobials, 8 (66.6%) also showed drug-resistant strains to this antimicrobial. 
These data suggest therapeutic failures and/or development of resistance during antibiotic 
therapy. 
          Metronidazole, was prescribed for patients with infections caused by Pseudomonas 
aeruginosa, it wasn´t a good antimicrobial choice, since metronidazole has antibacterial 
activity against Gram-positive sporulated microorganisms and anaerobic ones, not against 
Pseudomonas. Likewise, clindamycin and oxacillin have better indication for Gram-
positive and Gram-negative treatment, never for P. aeruginosa. 
 
4. CONCLUSIONS  
 
The high number of antimicrobials associations has been observed in some cases, 
for example, the association between imipenem, metronidazole, vancomycin and 
ceftriaxone used to treat one patient. In this case, therapy might have been effective due to 
the use of imipenem. It is relevant to note that imipenem should be the last choice therapy 
in a hospital setting to prevent the emergence of resistant strains. So the routine cultures 
with antibiogram should be mandatory, thus aiming effective and less harmful therapeutic 
choices to the hospital epidemiology. 
          P. aeruginosa demonstrated high resistance to antimicrobials used in hospital 
routine, showing, however, good sensitivity only to carbapenems (imipenem and 
meropenem), followed by ciprofloxacin and amikacin. 
            Considering the fact that several antimicrobials used empirically in routine hospital 
were not suitable for the treatment of patients with nosocomial infection, it is evident the 
need  for standardization and routine performance of tests for bacterial identification and 
antibiogram, to ensure therapeutic success and increased patient survival, helping to ensure 
the rational use of antimicrobials in the hospital. 
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